Quanterix Co. (NASDAQ:QTRX) Stock Position Increased by Algert Global LLC

Algert Global LLC lifted its position in Quanterix Co. (NASDAQ:QTRX) by 75.9% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 137,833 shares of the company’s stock after buying an additional 59,496 shares during the period. Algert Global LLC’s holdings in Quanterix were worth $1,786,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of the company. nVerses Capital LLC acquired a new stake in shares of Quanterix during the third quarter worth $60,000. SG Americas Securities LLC acquired a new stake in shares of Quanterix during the third quarter worth $139,000. Canada Pension Plan Investment Board acquired a new stake in shares of Quanterix during the second quarter worth $140,000. Hsbc Holdings PLC raised its position in shares of Quanterix by 34.7% during the second quarter. Hsbc Holdings PLC now owns 12,738 shares of the company’s stock worth $164,000 after purchasing an additional 3,279 shares during the period. Finally, Intech Investment Management LLC acquired a new stake in shares of Quanterix during the third quarter worth $170,000. Institutional investors own 86.48% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on the company. TD Cowen boosted their target price on Quanterix from $13.50 to $16.00 and gave the stock a “hold” rating in a research report on Wednesday, November 13th. Scotiabank cut their target price on Quanterix from $32.00 to $28.00 and set a “sector outperform” rating on the stock in a research report on Monday, August 12th.

Quanterix Trading Up 3.4 %

NASDAQ:QTRX opened at $12.47 on Thursday. The firm has a market capitalization of $478.60 million, a price-to-earnings ratio of -11.49 and a beta of 1.36. Quanterix Co. has a 1-year low of $10.50 and a 1-year high of $29.70. The business’s fifty day moving average price is $12.83 and its 200 day moving average price is $13.68.

About Quanterix

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.